Glenmede Trust’s Nu Skin NUS Stock Holding History

Glenmede Trust’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-50	Closed	-$2K	–	1887
2020 Q3	$2K	Hold	50	–	–	﹤0.01%	2273
2020 Q2	$1K	Buy	+50	New	+$1.61K	﹤0.01%	2346
2018 Q4	–	Sell	-21,796	Closed	-$1.8M	–	3064
2018 Q3	$1.8M	Buy	21,796 +36	+0.2%	+$2.86K	0.01%	664
2018 Q2	$1.7M	Buy	21,760 +21,725	+62,071%	+$1.68M	0.01%	629
2018 Q1	$2K	Hold	35	–	–	﹤0.01%	2602
2017 Q4	$2K	Buy	+35	New	+$2.26K	﹤0.01%	2602
2014 Q3	–	Sell	-127	Closed	-$9K	–	2494
2014 Q2	$9K	Hold	127	–	–	﹤0.01%	2066
2014 Q1	$10K	Sell	127 -624	-83%	-$54.8K	﹤0.01%	2045
2013 Q4	$103K	Sell	751 -434	-37%	-$51.1K	﹤0.01%	1391
2013 Q3	$113K	Sell	1,185 -114,150	-99%	-$9.69M	﹤0.01%	1330
2013 Q2	$7.05M	Buy	+115,335	New	+$6.4M	0.09%	258

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Glenmede Trust's NUS Position: Q4 2020 in Review

Glenmede Trust sold out of Nu Skin (NUS) in Q4 2020, closing a stake of 50 shares — an estimated $2K sold.

Glenmede Trust first reported a position in NUS in Q2 2013 and held it in 11 quarters. The position peaked at $7.05M in Q2 2013. 266 funds tracked by Wall St. Rank hold NUS as of Q4 2020.

Glenmede Trust reported no remaining Nu Skin position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 50 Nu Skin shares in Q4 2020, an estimated $2K.
Glenmede Trust first reported a position in Nu Skin in Q2 2013 and held it in 11 quarters.
Glenmede Trust's Nu Skin position peaked at $7.05M in Q2 2013.
266 funds tracked by Wall St. Rank held Nu Skin as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.